Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 11, 2020

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Myelofibrosis (MF)
Interventions
DRUG

ABBV-744

Tablet; Oral

DRUG

Navitoclax

Tablet; Oral

DRUG

Ruxolitinib

Tablet; Oral

Trial Locations (43)

1085

Duplicate_Semmelweis Egyetem /ID# 224085, Budapest

1199

Hospital Italiano de Buenos Aires /ID# 226945, Ciudad Autonoma Buenos Aires

1629

Hospital Universitario Austral /ID# 228909, Pilar

1797

SHAT Hematologic Diseases /ID# 226007, Sofia

3200

Clinexpert Kft. Fazis I Vizsgalohely /ID# 242249, Gyöngyös

4814

Townsville University Hospital /ID# 225859, Douglas

6000

Royal Perth Hospital /ID# 241678, Perth

7000

Royal Hobart Hospital /ID# 241677, Hobart

9010

UMHAT Sveta Marina /ID# 226681, Varna

10029

The Mount Sinai Hospital /ID# 221549, New York

10065

Weill Cornell Medical College /ID# 227069, New York

14263

Roswell Park Cancer Institute /ID# 222557, Buffalo

20122

Duplicate_Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 244397, Milan

28007

Hospital General Universitario Gregorio Maranon /ID# 233279, Madrid

34010

Koc Universitesi Hastanesi Translasyonel Tıp Arastırma Merkezi /ID# 234214, Istanbul

44718

Gabrail Cancer Center Research /ID# 222802, Canton

47392

Duplicate_Inje University Busan Paik Hospital /ID# 233707, Busan

91120

Hadassah Medical Center-Hebrew University /ID# 243852, Jerusalem

95817

University of California, Davis Comprehensive Cancer Center /ID# 221790, Sacramento

97239

Oregon Health and Science University /ID# 221801, Portland

4810469

Duplicate_Sociedad de Investigaciones Médicas Limitada /ID# 224175, Temuco

5265601

The Chaim Sheba Medical Center /ID# 222151, Ramat Gan

6423906

Tel Aviv Sourasky Medical Center /ID# 223548, Tel Aviv

7500921

Fundacion Arturo Lopez Perez /ID# 225037, Providencia

8241479

Icegclinic /Id# 231086, La Florida

03756

Duplicate_Dartmouth-Hitchcock Medical Center - 1 Medical Center Drive /ID# 224623, Lebanon

73104-5418

University of Oklahoma, Stephenson Cancer Center /ID# 224095, Oklahoma City

75246-2003

Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 240004, Dallas

98108-1597

VA Puget Sound Health Care System /ID# 224208, Seattle

74605-020

Hospital das Clinicas da Universidade Federal de Goiás /ID# 226636, Goiânia

90035-903

Hospital de Clinicas de Porto Alegre /ID# 226635, Porto Alegre

05652-900

Duplicate_Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein /ID# 226640, São Paulo

20231-050

Instituto Nacional de Cancer (INCA) /ID# 226637, Rio de Janeiro

01323-001

Real e Benemérita Associação Portuguesa de Beneficência /ID# 226641, São Paulo

05403-000

Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 226639, São Paulo

812-8582

Kyushu University Hospital /ID# 228035, Fukuoka

060-8648

Duplicate_Hokkaido University Hospital /ID# 228038, Sapporo

545-8586

Osaka Metropolitan University Hospital /ID# 225502, Osaka

409-3821

University of Yamanashi Hospital /ID# 225503, Chuo-shi

08041

Hospital Santa Creu i Sant Pau /ID# 238501, Barcelona

751 85

Akademiska Sjukhuset /ID# 228515, Uppsala

701 85

Orebro Universitetssjukhuset /ID# 228514, Örebro

06200

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi /ID# 234215, Ankara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY